Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Tnf Blocker
Pharma
EMA probes all JAKs after Xeljanz's safety concerns intensify
Europe is examining all JAK inhibitors after a clinical trial of Pfizer's Xeljanz showed recipients were more likely to have serious cardio issues.
Kevin Dunleavy
Feb 11, 2022 3:51pm
AbbVie's Humira could have a graceful biosim fall: analyst
Jul 12, 2021 11:27am
Long-term study shows safety, staying power of J&J's Stelara
Jul 9, 2021 11:10am
J&J touts Tremfya win in Humira-resistant psoriatic arthritis
Jun 3, 2021 11:40am
Bristol's Zeposia boost remission rates in ulcerative colitis
Oct 10, 2020 6:01pm
BMS' Zeposia angles for ulcerative colitis nod with new data
Jun 3, 2020 10:39am
